Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Genovese

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
EMBO Molecular Medicine|May 27, 2014
Targeted gene therapy and cell reprogramming in Fanconi anemiaPaula Rio, Rocio Baños, Angelo Lombardo, et al.
Blood|June 23, 2017
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host diseaseSara Mastaglio, Pietro Genovese, Zulma Magnani, et al.
EMBO Molecular Medicine|January 21, 2021
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndromeValentina Vavassori, Elisabetta Mercuri, Genni E Marcovecchio, et al.
Science Translational Medicine|February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiencyMaria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
EMBO Molecular Medicine|May 27, 2014
Targeted gene therapy and cell reprogramming in Fanconi anemiaPaula Rio, Rocio Baños, Angelo Lombardo, et al.
Blood|June 23, 2017
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host diseaseSara Mastaglio, Pietro Genovese, Zulma Magnani, et al.
EMBO Molecular Medicine|January 21, 2021
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndromeValentina Vavassori, Elisabetta Mercuri, Genni E Marcovecchio, et al.
Science Translational Medicine|February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiencyMaria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
Pageof 4